Skip to main content
Erschienen in: Endocrine 1/2011

01.08.2011 | Original Article

Influence of diabetes mellitus on vertebral fractures in men with acromegaly

verfasst von: Gherardo Mazziotti, Monica Gola, Antonio Bianchi, Teresa Porcelli, Antonella Giampietro, Vincenzo Cimino, Mauro Doga, Carmine Gazzaruso, Laura De Marinis, Andrea Giustina

Erschienen in: Endocrine | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Acromegaly is frequently complicated by fragility vertebral fractures and diabetes mellitus. Since type 2 diabetes mellitus is a cause of secondary osteoporosis in the general population, in this cross-sectional study we aimed at investigating the association between diabetes mellitus and vertebral fractures in males with acromegaly. Fifty-seven patients (median age 47 years, range: 24–85) with active (21 cases) and controlled (36 cases) acromegaly and 57 control subjects were evaluated for bone mineral density (BMD) by DXA and vertebral fractures by a quantitative morphometric analysis. Diabetes mellitus was found in 18 patients and 18 control subjects. The prevalence of vertebral fractures was higher in acromegalic patients as compared with the control subjects (50.9 vs. 10.5%; χ2: 21.8; P < 0.001). Acromegalic patients with fractures had serum IGF-I values significantly higher (P = 0.009), longer duration of active disease (P < 0.001) and higher prevalence of active acromegaly (P = 0.007) and diabetes mellitus (P = 0.04) as compared to patients who did not fracture. When acromegaly was active, the prevalence of vertebral fractures was high independently of the coexistent diabetes mellitus. On the contrary, when acromegaly was controlled the prevalence of vertebral fractures was significantly higher in patients with diabetes as compared to patients without diabetes (62.6 vs. 28.0%; P = 0.04). In both diabetic and non diabetic patients, vertebral fractures occurred independently of BMD. In conclusion, this study suggests that diabetes mellitus may be associated with an increased prevalence of vertebral fractures in males with acromegaly. However, this effect seems to be relatively attenuated in the presence of persistent GH hypersecretion.
Literatur
1.
Zurück zum Zitat A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)PubMedCrossRef A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)PubMedCrossRef
2.
Zurück zum Zitat E. Canalis, A. Giustina, J.P. Bilezikian, Mechanisms of anabolic therapies for osteoporosis. N. Engl. J. Med. 35, 7905–7916 (2007) E. Canalis, A. Giustina, J.P. Bilezikian, Mechanisms of anabolic therapies for osteoporosis. N. Engl. J. Med. 35, 7905–7916 (2007)
3.
Zurück zum Zitat S. Bonadonna, G. Mazziotti, M. Nuzzo, A. Bianchi, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J. Bone Miner. Res. 20, 1837–1844 (2005)PubMedCrossRef S. Bonadonna, G. Mazziotti, M. Nuzzo, A. Bianchi, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J. Bone Miner. Res. 20, 1837–1844 (2005)PubMedCrossRef
4.
Zurück zum Zitat G. Mazziotti, A. Bianchi, S. Bonadonna, V. Cimino, I. Patelli, A. Fusco, A. Pontecorvi, L. De Marinis, A. Giustina, Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocrinol. Metab. 93, 4649–4655 (2008)PubMedCrossRef G. Mazziotti, A. Bianchi, S. Bonadonna, V. Cimino, I. Patelli, A. Fusco, A. Pontecorvi, L. De Marinis, A. Giustina, Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocrinol. Metab. 93, 4649–4655 (2008)PubMedCrossRef
5.
Zurück zum Zitat M.J. Wassenaar, N.R. Biermasz, N.A. Hamdy, M.C. Zillikens, J.B. van Meurs, F. Rivadeneira, A. Hofman, A.G. Uitterlinden, M.P. Stokkel, F. Roelfsema, M. Kloppenburg, H.M. Kroon, J.A. Romijn, A.M. Pereira, High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur. J. Endocrinol. 164, 475–483 (2011)PubMedCrossRef M.J. Wassenaar, N.R. Biermasz, N.A. Hamdy, M.C. Zillikens, J.B. van Meurs, F. Rivadeneira, A. Hofman, A.G. Uitterlinden, M.P. Stokkel, F. Roelfsema, M. Kloppenburg, H.M. Kroon, J.A. Romijn, A.M. Pereira, High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur. J. Endocrinol. 164, 475–483 (2011)PubMedCrossRef
6.
Zurück zum Zitat A. Giustina, F.F. Casanueva, F. Cavagnini, P. Chanson, D. Clemmons, L.A. Frohman, R. Gaillard, K. Ho, P. Jaquet, D.L. Kleinberg, S.W. Lamberts, G. Lombardi, M. Sheppard, C.J. Strasburger, M.L. Vance, J.A. Wass, S. Melmed, Pituitary Society and the European Neuroendocrine Association, Diagnosis and treatment of acromegaly complications. J. Endocrinol. Invest. 26, 1242–1247 (2003)PubMed A. Giustina, F.F. Casanueva, F. Cavagnini, P. Chanson, D. Clemmons, L.A. Frohman, R. Gaillard, K. Ho, P. Jaquet, D.L. Kleinberg, S.W. Lamberts, G. Lombardi, M. Sheppard, C.J. Strasburger, M.L. Vance, J.A. Wass, S. Melmed, Pituitary Society and the European Neuroendocrine Association, Diagnosis and treatment of acromegaly complications. J. Endocrinol. Invest. 26, 1242–1247 (2003)PubMed
7.
Zurück zum Zitat G. Mazziotti, S. Bonadonna, M. Doga, I. Patelli, C. Gazzaruso, S.B. Solerte, E. De Menis, A. Giustina, Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. Neuroendocrinology 88, 299–304 (2008)PubMedCrossRef G. Mazziotti, S. Bonadonna, M. Doga, I. Patelli, C. Gazzaruso, S.B. Solerte, E. De Menis, A. Giustina, Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. Neuroendocrinology 88, 299–304 (2008)PubMedCrossRef
8.
Zurück zum Zitat G. Mazziotti, I. Floriani, S. Bonadonna, V. Torri, P. Chanson, A. Giustina, Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. J. Clin. Endocrinol. Metab. 94, 1500–1508 (2009)PubMedCrossRef G. Mazziotti, I. Floriani, S. Bonadonna, V. Torri, P. Chanson, A. Giustina, Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. J. Clin. Endocrinol. Metab. 94, 1500–1508 (2009)PubMedCrossRef
9.
Zurück zum Zitat A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr. Rev. 25, 102–152 (2004)PubMedCrossRef A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr. Rev. 25, 102–152 (2004)PubMedCrossRef
10.
Zurück zum Zitat M.L. Jaffrain-Rea, C. Moroni, R. Baldelli, C. Battista, P. Maffei, M. Terzolo, M. Correra, M.R. Ghiggi, E. Ferretti, A. Angeli, N. Sicolo, V. Trischitta, A. Liuzzi, R. Cassone, G. Tamburrano, Relationship between blood pressure and glucose tolerance in acromegaly. Clin. Endocrinol. (Oxf.) 54, 189–195 (2001)CrossRef M.L. Jaffrain-Rea, C. Moroni, R. Baldelli, C. Battista, P. Maffei, M. Terzolo, M. Correra, M.R. Ghiggi, E. Ferretti, A. Angeli, N. Sicolo, V. Trischitta, A. Liuzzi, R. Cassone, G. Tamburrano, Relationship between blood pressure and glucose tolerance in acromegaly. Clin. Endocrinol. (Oxf.) 54, 189–195 (2001)CrossRef
11.
Zurück zum Zitat A. Räkel, O. Sheehy, E. Rahme, J. LeLorier, Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab. 34, 193–205 (2008)PubMedCrossRef A. Räkel, O. Sheehy, E. Rahme, J. LeLorier, Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab. 34, 193–205 (2008)PubMedCrossRef
12.
Zurück zum Zitat P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos. Int. 18, 427–444 (2007)PubMedCrossRef P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos. Int. 18, 427–444 (2007)PubMedCrossRef
13.
Zurück zum Zitat T. Mancini, G. Mazziotti, M. Doga, R. Carpinteri, N. Simetovic, P.P. Vescovi, A. Giustina, Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone 45, 784–788 (2009)PubMedCrossRef T. Mancini, G. Mazziotti, M. Doga, R. Carpinteri, N. Simetovic, P.P. Vescovi, A. Giustina, Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone 45, 784–788 (2009)PubMedCrossRef
14.
Zurück zum Zitat A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526–529 (2000)PubMedCrossRef A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526–529 (2000)PubMedCrossRef
15.
Zurück zum Zitat A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, Acromegaly Consensus Group, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141–3148 (2010)PubMedCrossRef A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, Acromegaly Consensus Group, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141–3148 (2010)PubMedCrossRef
16.
17.
Zurück zum Zitat S. Melmed, A. Colao, A. Barkan, M. Molitch, A.B. Grossman, D. Kleinberg, D. Clemmons, P. Chanson, E. Laws, J. Schlechte, M.L. Vance, K. Ho, A. Giustina, Acromegaly Consensus Group, Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94, 1509–1517 (2009)PubMedCrossRef S. Melmed, A. Colao, A. Barkan, M. Molitch, A.B. Grossman, D. Kleinberg, D. Clemmons, P. Chanson, E. Laws, J. Schlechte, M.L. Vance, K. Ho, A. Giustina, Acromegaly Consensus Group, Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94, 1509–1517 (2009)PubMedCrossRef
18.
Zurück zum Zitat American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1), S62–S69 (2011)CrossRef American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1), S62–S69 (2011)CrossRef
19.
Zurück zum Zitat A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)PubMedCrossRef A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)PubMedCrossRef
20.
Zurück zum Zitat G. Mazziotti, E. Canalis, A. Giustina, Drug-induced osteoporosis: mechanisms and clinical implications. Am. J. Med. 123, 877–884 (2010)PubMedCrossRef G. Mazziotti, E. Canalis, A. Giustina, Drug-induced osteoporosis: mechanisms and clinical implications. Am. J. Med. 123, 877–884 (2010)PubMedCrossRef
21.
Zurück zum Zitat H.K. Genant, M. Jergas, L. Palermo, M. Nevitt, R.S. Valentin, D. Black, S.R. Cummings, Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11, 984–996 (1996)PubMedCrossRef H.K. Genant, M. Jergas, L. Palermo, M. Nevitt, R.S. Valentin, D. Black, S.R. Cummings, Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11, 984–996 (1996)PubMedCrossRef
22.
Zurück zum Zitat G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21, 520–528 (2006)PubMedCrossRef G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21, 520–528 (2006)PubMedCrossRef
23.
Zurück zum Zitat S. Ezzat, S. Melmed, D. Endres, D.R. Eyre, F.R. Singer, Biochemical assessment of bone formation and resorption in acromegaly. J. Clin. Endocrinol. Metab. 76, 1452–1457 (1993)PubMedCrossRef S. Ezzat, S. Melmed, D. Endres, D.R. Eyre, F.R. Singer, Biochemical assessment of bone formation and resorption in acromegaly. J. Clin. Endocrinol. Metab. 76, 1452–1457 (1993)PubMedCrossRef
24.
Zurück zum Zitat T. Ueland, E.N. Ebbesen, J.S. Thomsen, L. Mosekilde, K. Brixen, A. Flyvbjerg, J. Bollerslev, Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur. J. Clin. Invest. 32, 122–128 (2002)PubMedCrossRef T. Ueland, E.N. Ebbesen, J.S. Thomsen, L. Mosekilde, K. Brixen, A. Flyvbjerg, J. Bollerslev, Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur. J. Clin. Invest. 32, 122–128 (2002)PubMedCrossRef
25.
Zurück zum Zitat C. Battista, I. Chiodini, S. Muscarella, G. Guglielmi, M.L. Mascia, V. Carnevale, A. Scillitani, Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clin. Endocrinol. (Oxf.) 70, 378–382 (2009)CrossRef C. Battista, I. Chiodini, S. Muscarella, G. Guglielmi, M.L. Mascia, V. Carnevale, A. Scillitani, Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clin. Endocrinol. (Oxf.) 70, 378–382 (2009)CrossRef
26.
Zurück zum Zitat M.J. Wassenaar, N.R. Biermasz, J. Bijsterbosch, A.M. Pereira, I. Meulenbelt, J.W. Smit, F. Roelfsema, H.M. Kroon, J.A. Romijn, M. Kloppenburg, Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Ann. Rheum. Dis. 70, 320–325 (2011)PubMedCrossRef M.J. Wassenaar, N.R. Biermasz, J. Bijsterbosch, A.M. Pereira, I. Meulenbelt, J.W. Smit, F. Roelfsema, H.M. Kroon, J.A. Romijn, M. Kloppenburg, Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Ann. Rheum. Dis. 70, 320–325 (2011)PubMedCrossRef
27.
Zurück zum Zitat G.P. Lesse, W.D. Fraser, R. Farquharson, L. Hipkin, J.P. Vora, Gonadal status is an important determinant of bone density in acromegaly. Clin. Endocrinol. (Oxf.) 48, 59–65 (1998)CrossRef G.P. Lesse, W.D. Fraser, R. Farquharson, L. Hipkin, J.P. Vora, Gonadal status is an important determinant of bone density in acromegaly. Clin. Endocrinol. (Oxf.) 48, 59–65 (1998)CrossRef
28.
Zurück zum Zitat A. Scillitani, C. Battista, I. Chiodini, V. Carnevale, S. Fusilli, E. Ciccarelli, M. Terzolo, G. Oppizzi, M. Arosio, M. Gasperi, G. Arnaldi, A. Colao, R. Baldelli, M.R. Ghiggi, D. Gaia, C. Di Somma, V. Trischitta, A. Liuzzi, Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clin. Endocrinol. (Oxf.) 58, 725–731 (2003)CrossRef A. Scillitani, C. Battista, I. Chiodini, V. Carnevale, S. Fusilli, E. Ciccarelli, M. Terzolo, G. Oppizzi, M. Arosio, M. Gasperi, G. Arnaldi, A. Colao, R. Baldelli, M.R. Ghiggi, D. Gaia, C. Di Somma, V. Trischitta, A. Liuzzi, Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clin. Endocrinol. (Oxf.) 58, 725–731 (2003)CrossRef
29.
Zurück zum Zitat T.L. Clemens, G. Karsenty, The osteoblast: an insulin target cell controlling glucose homeostasis. J. Bone Miner. Res. 26, 677–680 (2011)PubMedCrossRef T.L. Clemens, G. Karsenty, The osteoblast: an insulin target cell controlling glucose homeostasis. J. Bone Miner. Res. 26, 677–680 (2011)PubMedCrossRef
30.
Zurück zum Zitat C.J. Rosen, K.J. Motyl, No bones about it: insulin modulates skeletal remodeling. Cell 142, 98–200 (2010)CrossRef C.J. Rosen, K.J. Motyl, No bones about it: insulin modulates skeletal remodeling. Cell 142, 98–200 (2010)CrossRef
31.
Zurück zum Zitat N.K. Lee, H. Sowa, E. Hinoi, M. Ferron, J.D. Ahn, C. Confavreux, R. Dacquin, P.J. Mee, M.D. McKee, D.Y. Jung, Z. Zhang, J.K. Kim, F. Mauvais-Jarvis, P. Ducy, G. Karsenty, Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456–469 (2007)PubMedCrossRef N.K. Lee, H. Sowa, E. Hinoi, M. Ferron, J.D. Ahn, C. Confavreux, R. Dacquin, P.J. Mee, M.D. McKee, D.Y. Jung, Z. Zhang, J.K. Kim, F. Mauvais-Jarvis, P. Ducy, G. Karsenty, Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456–469 (2007)PubMedCrossRef
32.
Zurück zum Zitat J.M. Gimble, M.E. Nuttall, Bone and fat: old questions, new insights. Endocrine 23, 183–188 (2004)PubMedCrossRef J.M. Gimble, M.E. Nuttall, Bone and fat: old questions, new insights. Endocrine 23, 183–188 (2004)PubMedCrossRef
33.
Zurück zum Zitat K. Ağbaht, A. Gürlek, J. Karakaya, M. Bayraktar, Circulating adiponectin represents a biomarker of the association between adiposity and bone mineral density. Endocrine 35, 371–379 (2009)PubMedCrossRef K. Ağbaht, A. Gürlek, J. Karakaya, M. Bayraktar, Circulating adiponectin represents a biomarker of the association between adiposity and bone mineral density. Endocrine 35, 371–379 (2009)PubMedCrossRef
34.
Zurück zum Zitat I. Kanazawa, T. Yamaguchi, M. Yamamoto, M. Yamauchi, S. Yano, T. Sugimoto, Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur. J. Endocrinol. 160, 265–273 (2009)PubMedCrossRef I. Kanazawa, T. Yamaguchi, M. Yamamoto, M. Yamauchi, S. Yano, T. Sugimoto, Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur. J. Endocrinol. 160, 265–273 (2009)PubMedCrossRef
35.
Zurück zum Zitat N. Sucunza, M.J. Barahona, E. Resmini, J.M. Fernández-Real, W. Ricart, J. Farrerons, J. Rodríguez Espinosa, A.M. Marin, T. Puig, S.M. Webb, A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. J. Clin. Endocrinol. Metab. 94, 3889–3896 (2009)PubMedCrossRef N. Sucunza, M.J. Barahona, E. Resmini, J.M. Fernández-Real, W. Ricart, J. Farrerons, J. Rodríguez Espinosa, A.M. Marin, T. Puig, S.M. Webb, A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. J. Clin. Endocrinol. Metab. 94, 3889–3896 (2009)PubMedCrossRef
36.
Zurück zum Zitat M.C. Nevitt, B. Ettinger, D.M. Black, K. Stone, S.A. Jamal, K. Ensrud, M. Segal, H.K. Genant, S.R. Cummings, The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann. Intern. Med. 128, 793–800 (1998)PubMed M.C. Nevitt, B. Ettinger, D.M. Black, K. Stone, S.A. Jamal, K. Ensrud, M. Segal, H.K. Genant, S.R. Cummings, The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann. Intern. Med. 128, 793–800 (1998)PubMed
37.
Zurück zum Zitat T. Jalava, S. Sarna, L. Pylkkänen, B. Mawer, J.A. Kanis, P. Selby, M. Davies, J. Adams, R.M. Francis, J. Robinson, E. McCloskey, Association between vertebral fracture and increased mortality in osteoporotic patients. J. Bone Miner. Res. 18, 1254–1260 (2003)PubMedCrossRef T. Jalava, S. Sarna, L. Pylkkänen, B. Mawer, J.A. Kanis, P. Selby, M. Davies, J. Adams, R.M. Francis, J. Robinson, E. McCloskey, Association between vertebral fracture and increased mortality in osteoporotic patients. J. Bone Miner. Res. 18, 1254–1260 (2003)PubMedCrossRef
38.
Zurück zum Zitat S. Bossoni, G. Mazziotti, C. Gazzaruso, D. Martinelli, S. Orini, S.B. Solerte, G. Romanelli, A. Giustina, Relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes. Age Ageing 37, 222–225 (2008)PubMedCrossRef S. Bossoni, G. Mazziotti, C. Gazzaruso, D. Martinelli, S. Orini, S.B. Solerte, G. Romanelli, A. Giustina, Relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes. Age Ageing 37, 222–225 (2008)PubMedCrossRef
39.
Zurück zum Zitat M. Sherlock, J. Ayuk, J.W. Tomlinson, A.A. Toogood, A. Aragon-Alonso, M.C. Sheppard, A.S. Bates, P.M. Stewart, Mortality in patients with pituitary disease. Endocr. Rev. 31, 301–342 (2010)PubMedCrossRef M. Sherlock, J. Ayuk, J.W. Tomlinson, A.A. Toogood, A. Aragon-Alonso, M.C. Sheppard, A.S. Bates, P.M. Stewart, Mortality in patients with pituitary disease. Endocr. Rev. 31, 301–342 (2010)PubMedCrossRef
40.
Zurück zum Zitat G. Mazziotti, A. Bianchi, V. Cimino, S. Bonadonna, P. Martini, A. Fusco, L. De Marinis, A. Giustina, Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. Pituitary 11, 55–61 (2008)PubMedCrossRef G. Mazziotti, A. Bianchi, V. Cimino, S. Bonadonna, P. Martini, A. Fusco, L. De Marinis, A. Giustina, Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. Pituitary 11, 55–61 (2008)PubMedCrossRef
41.
Zurück zum Zitat G. Mazziotti, T. Porcelli, M. Mormando, E. De Menis, A. Bianchi, C. Mejia, T. Mancini, L. De Marinis, A. Giustina, Vertebral fractures in males with prolactinoma. Endocrine 39, 288–293 (2011)PubMedCrossRef G. Mazziotti, T. Porcelli, M. Mormando, E. De Menis, A. Bianchi, C. Mejia, T. Mancini, L. De Marinis, A. Giustina, Vertebral fractures in males with prolactinoma. Endocrine 39, 288–293 (2011)PubMedCrossRef
Metadaten
Titel
Influence of diabetes mellitus on vertebral fractures in men with acromegaly
verfasst von
Gherardo Mazziotti
Monica Gola
Antonio Bianchi
Teresa Porcelli
Antonella Giampietro
Vincenzo Cimino
Mauro Doga
Carmine Gazzaruso
Laura De Marinis
Andrea Giustina
Publikationsdatum
01.08.2011
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2011
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9486-x

Weitere Artikel der Ausgabe 1/2011

Endocrine 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.